Sumatriptan + Escitalopram Oxalate Interaction
Majorinteraction on record
Description
Postmarketing reports describe weakness, hyperreflexia, and incoordination following concomitant use. Appropriate patient observation is advised if concomitant treatment is clinically warranted.
Mechanism
Serotonin syndrome risk
Source: NLP:escitalopram oxalate